Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors. J Am Acad Dermatol 2020 Jun;82(6):e253-e254
Date
02/29/2020Pubmed ID
32109540DOI
10.1016/j.jaad.2020.02.052Scopus ID
2-s2.0-85084370572 (requires institutional sign-in at Scopus site) 6 CitationsAuthor List
Cohen PR, Kurzrock RAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Carcinoma, Basal CellHumans
Programmed Cell Death 1 Receptor
Skin Neoplasms
